Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023

Childhood cancer: The surprising scientific facts

Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia
Childhood cancer: The surprising scientific facts ( Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023

Choosing Wisely in medical oncology

Dr Omar AbdiHamid - Garissa Cancer Center, Garissa, Kenya
Choosing Wisely in medical oncology ( Dr Omar AbdiHamid - Garissa Cancer Center, Garissa, Kenya )
25 Apr 2023

Hemopathy burden at National Cancer Center

Dr Kao Vannarith - Calmette Hospital, Phnom Penh, Cambodia
Hemopathy burden at National Cancer Center ( Dr Kao Vannarith - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023

To avoid unnecessary second surgery in differentiated thyroid cancer

Dr Thou Sarameth - Calmette Hospital, Phnom Penh, Cambodia
To avoid unnecessary second surgery in  differentiated thyroid cancer ( Dr Thou Sarameth - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023

Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023

Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma

Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan
Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma ( Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan )
21 Apr 2023

The importance of providing post-treatment care to cancer survivors

Dr Lidia Schapira - Stanford Medicine, California, USA
The importance of providing post-treatment care to cancer survivors ( Dr Lidia Schapira - Stanford Medicine, California, USA )
20 Apr 2023

Cancer Survivorship

Dr Lidia Schapira - Stanford Medicine, California, USA
Cancer Survivorship ( Dr Lidia Schapira - Stanford Medicine, California, USA )
20 Apr 2023

Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM

Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA
Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM ( Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA )
20 Apr 2023

Cancer Care in Older Adults and Special Population

Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA
Cancer Care in Older Adults and Special Population ( Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA )
20 Apr 2023

The clinical impact of the Choosing Wisely project

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
The clinical impact of the Choosing Wisely project ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023